Atossa Therapeutics, Inc.
ATOS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$25,504 | -$30,094 | -$26,960 | -$20,606 |
| Dep. & Amort. | $17 | $23 | $8 | $23 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $2,292 | $4,621 | $6,788 | $5,267 |
| Change in WC | $448 | $1,519 | -$599 | -$1,156 |
| Other Non-Cash | $1,717 | $2,990 | $3 | $0 |
| Operating Cash Flow | -$21,030 | -$20,941 | -$20,760 | -$16,472 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$19 | -$14 | -$27 | -$9 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | -$4,700 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$19 | -$14 | -$4,727 | -$9 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $3,673 | $0 | $0 | $69,668 |
| Stock Repurch. | $0 | -$1,475 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $43,636 |
| Financing Cash Flow | $3,673 | -$1,475 | $0 | $113,304 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$17,376 | -$22,430 | -$25,487 | $96,823 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $88,570 | $111,000 | $136,487 | $39,664 |
| End Cash | $71,194 | $88,570 | $111,000 | $136,487 |
| Free Cash Flow | -$21,049 | -$20,955 | -$20,787 | -$16,481 |